WallStSmart
NVAX

Novavax Inc

NASDAQ: NVAX · HEALTHCARE · BIOTECHNOLOGY

$7.93
-0.56% today

Updated 2026-04-30

Market cap
$1.31B
P/E ratio
3.09
P/S ratio
1.17x
EPS (TTM)
$2.58
Dividend yield
52W range
$6 – $12
Volume
4.2M

Novavax Inc (NVAX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-14.81M$-26.74M$-24.31M$-32.83M$-32.85M$-23.63M$-18.23M$-45.36M$-67.01M$-126.09M$-255.47M$-138.70M$-184.82M$-136.62M$-42.54M$322.95M$-415.94M$-713.97M$-87.26M$-244.63M
Capital expenditures$1.52M$1.96M$5.69M$745000.00$1.56M$610000.00$4.34M$5.79M$7.27M$18.29M$18.21M$4.19M$1.37M$1.86M$54.62M$57.49M$92.98M$58.81M$13.06M$5.56M
Depreciation$2.71M$-1.01M$893000.00$1.19M$1.37M$1.61M$1.67M$2.59M$4.42M$5.98M$8.51M$9.82M$8.16M$5.68M$4.88M$12.66M$29.05M$41.23M$48.50M
Stock-based comp$2.27M$1.80M$2.07M$1.53M$1.34M$2.05M$2.09M$2.48M$6.09M$13.43M$19.16M$19.81M$18.31M$17.05M$128.03M$183.63M$130.30M$85.36M$48.15M$36.02M
Free cash flow$-16.33M$-28.70M$-30.00M$-33.58M$-34.41M$-24.24M$-22.57M$-51.14M$-74.28M$-144.38M$-273.68M$-142.88M$-186.20M$-138.48M$-97.16M$265.46M$-508.92M$-772.77M$-100.32M$-250.19M
Investing cash flow$-66.81M$24.65M$29.91M$2.35M$-21.27M$18.54M$-32.26M$16.39M$-129.83M$-21.27M$28.02M$35.97M$28.60M$38.49M$-377.78M$100.15M$-92.98M$-58.81M$-204.04M
Financing cash flow$56.89M$-720000.00$16.99M$42.29M$23.43M$11.13M$53.79M$131.03M$109.72M$208.28M$279.03M$64.54M$102.81M$98.38M$984.76M$461.71M$324.99M$4.47M$260.58M
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$39.09M
Share repurchases
Debt repayment
Net change in cash$6.04M$3.29M$102.07M$-87.14M$60.77M$51.24M$-38.05M$-53.42M$253000.00$564.44M$884.81M